Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics to predict drug-related adverse events.

Toxicologic pathology - 1 Jan 2000

Hosford David A, Lai Eric H, Riley John H, Xu Chun-Fang, Danoff Theodore M, Roses Allen D

Abstract excerpt

Identification of reliable markers to predict drug-related adverse events (DRAEs) is an important goal of the pharmaceutical industry and others within the healthcare community. We have used genetic polymorphisms, including the most frequent source of variation (single nucleotide polymorphisms, SNPs) in the human genome, in pharmacogenetic approaches designed to predict DRAEs. Three studies exemplify the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Predictive Value of Tests
Share to Alzheimer Disease
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dideoxynucleosides

Share to Glucuronosyltransferase

Share to HIV Infections

Share to ortho-Aminobenzoates

Share to Pharmacogenetics

Source

Identifiers

PMID: 15209398
DOI: 10.1080/01926230490424743

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics to predict drug-related adverse events.PMID 15209398Read ↗

Pharmacogenetics of Adverse Drug Reactions.Semantic proximity Read ↗

Identification of a pharmacogenetic effect by linkage disequilibrium mapping.Semantic proximity Read ↗

Digging up the human genome: current progress in deciphering adverse drug reactions.Semantic proximity Read ↗

Pharmacogenomics of adverse drug reactions: practical applications and perspectives.Semantic proximity Read ↗

Pharmacogenetic testing: proofs of principle and pharmacoeconomic implications.Semantic proximity Read ↗

Pharmacogenetics of idiosyncratic adverse drug reactions.Semantic proximity Read ↗

Genetic susceptibility to adverse drug reactions.Semantic proximity Read ↗

Pharmacogenetics of Gilbert's syndrome.Semantic proximity Read ↗

Genomics of Adverse Drug Reactions.Semantic proximity Read ↗

Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach.Semantic proximity Read ↗

Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions.Semantic proximity Read ↗

Pharmacogenetics and Predictive Testing of Drug Hypersensitivity ReactionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.